Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM52PE
HR+
Luminal
Purvalanol A
CDK1
CDK
7541.067
uM
15.23910
15.42490
0.0199 -0.0090 1.4644 0.2301
0.9623
1.4459
SUM52PE
HR+
Luminal
SB-3CT
MMP2/9
MMP
11852.144
uM
inf
25.94550
0.6006 0.6001 4.8149 0.0038
0.9292
1.2876
SUM52PE
HR+
Luminal
SB-3CT
MMP2/9
MMP
10695.144
uM
20.92760
25.58980
-0.8646 -0.8666 4.9994 0.1286
0.9946
1.2333
SUM52PE
HR+
Luminal
Selumetinib
MEK
MAPK
11852.155
uM
13.44280
3.97070
0.4002 0.3713 1.1129 0.1293
0.9810
1.5196
SUM52PE
HR+
Luminal
Selumetinib
MEK
MAPK
10695.146
uM
11.59760
6.51090
0.3182 0.2851 1.4625 0.0955
0.9832
1.4179
SUM52PE
HR+
Luminal
Sigma A6730
AKT
AKT
10695.153
uM
1.37770
5.1960
-0.8869 -1.0000 0.8276 0.4248
0.9818
1.4050
SUM52PE
HR+
Luminal
Sigma A6730
AKT
AKT
11852.158
uM
1.58830
5.7660
-0.9078 -1.0000 0.8521 0.3847
0.9842
1.3172
SUM52PE
HR+
Luminal
Sirolimus
MTOR
MTOR
7540.068
uM
0.00006
0.02391
-0.9666 -1.0000 0.1851 1.1952
0.7788
0.9679
SUM52PE
HR+
Luminal
Sirolimus
MTOR
MTOR
7541.069
uM
0.00929
0.41233
-0.4334 -0.6820 0.2268 0.6661
0.8344
1.5197
SUM52PE
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7541.084
uM
1.81090
6.40210
-0.6430 -0.5390 0.5792 0.5861
0.9414
1.2092
SUM52PE
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7541.067
uM
1.20340
3.27480
-0.9936 -1.0000 1.0974 0.6535
0.9933
1.4459
SUM52PE
HR+
Luminal
Taxol
TUBB
TUBB
12969.002
uM
0.00472
0.0040
0.1005 0.1359 1.9204 0.6282
0.8872
1.0653
SUM52PE
HR+
Luminal
Taxol
TUBB
TUBB
9889.002
uM
0.00261
0.00339
-0.4047 -0.3473 2.0228 0.9632
0.9952
1.1879
SUM52PE
HR+
Luminal
Taxol
TUBB
TUBB
9878.002
uM
0.00699
0.00894
-0.4289 -0.3904 2.3439 0.8797
0.9958
1.3437
SUM52PE
HR+
Luminal
TCS 2312
CHK1
CHK
11852.159
uM
0.36432
0.50909
-0.5787 -0.4125 1.7981 0.4497
0.9793
1.3247
SUM52PE
HR+
Luminal
TCS 2312
CHK1
CHK
10695.152
uM
0.39667
0.56843
-0.6108 -0.5773 2.1334 0.4949
0.9984
1.2495
SUM52PE
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10695.148
uM
14.9730
46.8350
-0.1802 -1.0000 0.9634 0.1796
0.9788
1.5078
SUM52PE
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
11852.135
uM
26.48710
26.44040
0.0047 0.0044 5.0000 0.0852
0.9843
1.2467
SUM52PE
HR+
Luminal
Temsirolimus
MTOR
MTOR
10695.144
uM
0.00009
0.11643
-0.9723 -1.0000 0.1538 1.0263
0.6812
1.2333
SUM52PE
HR+
Luminal
Temsirolimus
MTOR
MTOR
11852.144
uM
0.00436
0.03753
-0.3336 -0.3874 0.2665 0.8256
0.8074
1.2876
SUM52PE
HR+
Luminal
Topotecan
TOP1
TOP
7540.078
uM
0.00839
0.02466
-0.7407 -0.7887 0.8780 1.1756
0.9868
0.9523
SUM52PE
HR+
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10695.15
uM
0.41910
0.92056
-0.4728 -0.5248 0.9120 0.4451
0.9829
1.3520
SUM52PE
HR+
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
11852.16
uM
0.34294
0.72463
-0.3662 -0.4251 0.8224 0.4315
0.9931
1.2383
SUM52PE
HR+
Luminal
TPCA-1
IKK
NFKB
7539.093
uM
0.47224
0.74636
0.0991 -0.0997 0.3971 0.4229
0.8010
1.5919
SUM52PE
HR+
Luminal
Trametinib
MEK
MAPK
7540.05
uM
0.12639
0.01882
0.2120 0.3321 0.5730 0.3383
0.8729
0.6835